Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
The largest contributors to the Fund’s performance in the first quarter included ADMA Biologics (ADMA) and SPOK Holdings (SPOK). We’ve followed ADMA...
— Andrew Summers
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on ADMA Biologics, Inc.
No other institutional pitches found for this ticker yet.
More institutional theses from Summers Value Fund
Electromed delivered record-breaking sales, earnings, and cash generation under a new leadership team, causing the stock to soar by 176%. The company's SmartVest...
UFP Technologies continued its outstanding run in 2024, bolstered by acquisitions and a growing relationship with Intuitive Surgical. The manager trimmed...
The fund initiated a position in Indivior at an attractive valuation of 10x expected earnings after a guidance cut caused a temporary stock drop. The manager expects...